Understanding the Different Forms of Carbidopa/Levodopa: Additional Questions Answered Posted on April 29, 2025May 14, 2025 by Rebecca Gilbert, MD, Ph.D. Exploring the New Forms of Carbidopa/Levodopa with Dr. Vaou On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with...see more Dr. Okeanis Vaou, a movement disorders specialist, about the various new formulations of carbidopa/levodopa that are available, including Crexont® and Vyalev®, among others. Carbidopa/levodopa is the mainstay of treatment for Parkinson’s disease (PD) and is […] Read More
Exploring the Variations of Carbidopa/Levodopa: The Mainstay of Parkinson’s Disease Treatment Posted on October 8, 2024October 22, 2024 by Rebecca Gilbert, MD, Ph.D. How carbidopa/levodopa is used to treat Parkinson’s disease symptoms Loss of neurons in the brain that use dopamine to...see more communicate is one of the hallmark features of Parkinson’s disease (PD), causing slowness, stiffness, tremor, and balance problems. Replacing the brain’s dopamine is therefore one of the key treatment strategies to help improve the motor symptoms […] Read More
Carbidopa/Levodopa: Side Effects, Dosages, and More Posted on June 4, 2024October 10, 2024 by Rebecca Gilbert, MD, Ph.D. Carbidopa/Levodopa: Answers to the Frequently Asked Questions Dr. Gilbert gives in-depth answers to common questions that many ask with regards...see more to carbidopa/levodopa treatment for Parkinson’s disease. Read More
Ribonucleic Acid (RNA) and its Role in Parkinson’s Disease (PD) and Levodopa-induced Dyskinesias Posted on March 12, 2024March 11, 2024 by Rebecca Gilbert, MD, Ph.D. An Interview With Dr. Krithi Irmady, an APDA Researcher Studying RNA & Parkinson’s Our A Closer Look blog is designed to...see more educate, inform, and inspire you through a variety of topics and insights about Parkinson’s disease (PD). One way we do that is through our Interview with APDA Researchers series within this blog so you can get a closer […] Read More
The Role of Dopamine Agonists in Parkinson’s Treatment Posted on February 27, 2024June 24, 2024 by css-admin What are dopamine receptor agonists? These medicines constitute a class of drugs used to treat Parkinson’s disease (PD) symptoms that...see more mimic the action of naturally occurring dopamine. Although this class of medication is less potent than levodopa, they can be very beneficial in treating symptoms for long periods of time. Read More
Use of Cannabidiol (CBD) for PD symptoms Posted on February 9, 2024October 15, 2024 by Rebecca Gilbert, MD, Ph.D. Understanding CBD People with PD are eager to find alternative methods to help their symptoms, leading many of these patients...see more to look into whether other therapies, such as medical marijuana, also known as medical cannabis, can be useful. Previously, I wrote a blog on medical marijuana and PD which you may find interesting. More recently, I […] Read More
Interactions between Levodopa and food – What to Avoid Posted on November 2, 2023June 24, 2024 by Rebecca Gilbert, MD, Ph.D. The challenges of levodopa dosing and food intake I receive many Ask the Doctor questions about food intake and...see more levodopa ingestion, and I know it’s a tough balance for many. Instructions on how best to take levodopa can seem contradictory. On one hand, people with Parkinson’s disease (PD) are told to separate levodopa from food […] Read More
Drug-induced parkinsonism Posted on September 29, 2023June 12, 2024 by Rebecca Gilbert, MD, Ph.D. What is drug-induced parkinsonism? The motor features of PD are often (but not always) very easy to see via a...see more neurologic exam in a doctor’s office. Rest tremor (which is a tremor that goes away with movement, but often returns when the limb is at rest) for example, is seen in virtually no other illness and can […] Read More
Five Myths About Levodopa Posted on March 22, 2022May 12, 2022 by Rebecca Gilbert, MD, Ph.D. Levodopa and Parkinson’s Disease When prescribed, levodopa is extremely effective in treating the motor symptoms of Parkinson’s disease (PD)...see more and is embraced by many with PD. Many individuals see using Levodopa as a vital ingredient in maintaining movement and quality of life. It is the most prescribed medication for PD and has been the mainstay […] Read More
The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease Posted on January 8, 2020July 15, 2024 by Rebecca Gilbert, MD, Ph.D. The FDA recently approved Fluorodopa...see more F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that can help visualize the nerve endings of dopaminergic neurons. It can be used to help in the diagnosis of Parkinson’s disease (PD) and other parkinsonian […] Read More
